A prospective multicentre study evaluating the performance of the modified simple biliary atresia scoring system in predicting biliary atresia
Topic overview
This prospective study validates a modified Simple BA Scoring System for diagnosing biliary atresia in infants with cholestatic jaundice, achieving 96% sensitivity and 86% accuracy at a cut-off score of 3. The bedside scoring tool combines ultrasound findings, biochemical markers, and clinical parameters to reduce unnecessary surgical explorations in neonates.
Key takeaways
- Modified SBASS (score 0-6) uses 4 parameters: GB length <1.6cm, triangular cord sign, conjugated/total bilirubin >0.7, and GGT ≥200 U/L
- At cutoff ≥3, modified SBASS achieved 96.2% sensitivity and 86.3% accuracy for diagnosing biliary atresia in 73 cholestatic infants
- GGT ≥200 U/L showed highest sensitivity (94.2%) while triangular cord sign had highest specificity (95.2%) for BA diagnosis
- SBASS provides bedside, non-invasive tool to exclude BA and reduce unnecessary surgical explorations in infantile cholestasis
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. A prospective multicentre study evaluating the performance of the modified simple biliary atresia scoring system in predicting biliary atresia. GlobalCastMD Medical Library. 2024-08-27. https://dev.library.globalcastmd.com/article/9079?via_space=staycurrentmd
Comments